151 related articles for article (PubMed ID: 37498992)
21. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.
Xu TM; Cui MH; Xin Y; Gu LP; Jiang X; Su MM; Wang DD; Wang WJ
Chin Med J (Engl); 2008 Aug; 121(15):1394-7. PubMed ID: 18959116
[TBL] [Abstract][Full Text] [Related]
22. Ginsenoside Rg3 inhibits pulmonary fibrosis by preventing HIF-1α nuclear localisation.
Fu Z; Xu YS; Cai CQ
BMC Pulm Med; 2021 Feb; 21(1):70. PubMed ID: 33639908
[TBL] [Abstract][Full Text] [Related]
23. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells.
Chen QJ; Zhang MZ; Wang LX
Cell Physiol Biochem; 2010; 26(6):849-58. PubMed ID: 21220916
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy.
Li L; Ni J; Li M; Chen J; Han L; Zhu Y; Kong D; Mao J; Wang Y; Zhang B; Zhu M; Gao X; Fan G
Drug Deliv; 2017 Nov; 24(1):1617-1630. PubMed ID: 29063791
[TBL] [Abstract][Full Text] [Related]
25. Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton.
Wu W; Zhou Q; Zhao W; Gong Y; Su A; Liu F; Liu Y; Li Z; Zhu J
J Med Food; 2018 Sep; 21(9):849-857. PubMed ID: 30136914
[TBL] [Abstract][Full Text] [Related]
26. Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt.
Wang X; Chen L; Wang T; Jiang X; Zhang H; Li P; Lv B; Gao X
Phytomedicine; 2015 Sep; 22(10):875-84. PubMed ID: 26321736
[TBL] [Abstract][Full Text] [Related]
27. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
[TBL] [Abstract][Full Text] [Related]
28. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
29. Bioinspired ginsenoside Rg3 PLGA nanoparticles coated with tumor-derived microvesicles to improve chemotherapy efficacy and alleviate toxicity.
Zhang S; Zheng B; Wei Y; Liu Y; Yang L; Qiu Y; Su J; Qiu M
Biomater Sci; 2024 May; 12(10):2672-2688. PubMed ID: 38596867
[TBL] [Abstract][Full Text] [Related]
30. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells.
Chen J; Peng H; Ou-Yang X; He X
Melanoma Res; 2008 Oct; 18(5):322-9. PubMed ID: 18781130
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rg1 promotes cerebral angiogenesis via the PI3K/Akt/mTOR signaling pathway in ischemic mice.
Chen J; Zhang X; Liu X; Zhang C; Shang W; Xue J; Chen R; Xing Y; Song D; Xu R
Eur J Pharmacol; 2019 Aug; 856():172418. PubMed ID: 31132356
[TBL] [Abstract][Full Text] [Related]
33. The angiosuppressive effects of 20(R)- ginsenoside Rg3.
Yue PY; Wong DY; Wu PK; Leung PY; Mak NK; Yeung HW; Liu L; Cai Z; Jiang ZH; Fan TP; Wong RN
Biochem Pharmacol; 2006 Aug; 72(4):437-45. PubMed ID: 16793023
[TBL] [Abstract][Full Text] [Related]
34. Ginsenoside Rg3 attenuates ovariectomy-induced osteoporosis via AMPK/mTOR signaling pathway.
Zhang X; Huang F; Chen X; Wu X; Zhu J
Drug Dev Res; 2020 Nov; 81(7):875-884. PubMed ID: 32898934
[TBL] [Abstract][Full Text] [Related]
35. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
Zou J; Su H; Zou C; Liang X; Fei Z
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
[TBL] [Abstract][Full Text] [Related]
36. Experimental Evidence for the Anti-Metastatic Action of Ginsenoside Rg3: A Systematic Review.
Oh HM; Cho CK; Son CG
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012338
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.
Meng L; Ji R; Dong X; Xu X; Xin Y; Jiang X
Int J Oncol; 2019 Jun; 54(6):2069-2079. PubMed ID: 31081060
[TBL] [Abstract][Full Text] [Related]
38. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
Kang XM; Zhang QY; Tong DD; Zhao W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
[TBL] [Abstract][Full Text] [Related]
39. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
Lu M; Fei Z; Zhang G
Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
